During the past decade, Hôpital de Poissy; Service neurologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hôpital de Poissy; Service neurologie" are "Multiple Sclerosis" (1 trials), "Multiple Sclerosis, Primary Progressive" (1 trials) and "Multiple Sclerosis, Relapsing-Remitting" (1 trials). Many other conditions were trialed in "Hôpital de Poissy; Service neurologie" in a lesser frequency.

Most popular intervention types in "Hôpital de Poissy; Service neurologie" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (3 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital de Poissy; Service neurologie" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Hôpital de Poissy; Service neurologie". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hôpital de Poissy; Service neurologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital de Poissy; Service neurologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".